NOV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nov Inc

Watchlist Manager

Watchlist

Price: 18.89 USD 2.5%

Market Cap: $6.8B

	Nov Inc NYSE:NOV	US
	Deutsche EuroShop AG XETRA:DEQ	DE
	Kinarus Therapeutics Holding AG SIX:CURN	CH
	Cartesian Therapeutics Inc NASDAQ:RNAC	US
S	Sinopharm Group Co Ltd XMUN:X2S	CN
F	Freeport-McMoRan Inc DUS:FPMB	US
P	PennantPark Floating Rate Capital Ltd LSE:0KH0	US
G	General Dynamics Corp XETRA:GDX	US
A	Applied Materials Inc HKEX:4336	US
W	Westlake Corp F:UEO	US
A	Anycolor Inc TSE:5032	JP
T	Travelers Companies Inc F:PA9	US
	Altius Renewable Royalties Corp TSX:ARR	CA
	Tenaris SA MIL:TEN	LU
	Delivery Hero SE OTC:DLVHF	DE

Profitability Summary

Nov Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

20%

Sustainable 3Y Average Gross Margin

22%

Declining Gross Margin

21% > 20%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

7% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

5% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-6% > 8%

Low ROE

Positive 3Y Average ROE